High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-10-01
Col·lecció:Cells
Matèries:
osteosarcoma
high-grade bone sarcoma
pediatric bone tumors
ifosfamide
chemotherapy
PARP1
Accés en línia:https://www.mdpi.com/2073-4409/9/11/2389
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars